Cost-effectiveness of WISEWOMAN, a program aimed at reducing heart disease risk among low-income women

Journal of Women's Health

Volumn 15, Issue 4, 2006, Pages 379-389

  Finkelstein, Eric A ^a   Khavjou, Olga ^a   Will, Julie C ^b  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ARTICLE; CALCULATION; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEALTH SERVICE; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LIFESTYLE; LOWEST INCOME GROUP; PATIENT PARTICIPATION; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS; SMOKING; SYSTOLIC BLOOD PRESSURE; UNCERTAINTY;

CARDIOVASCULAR DISEASES; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; LIFE STYLE; MASSACHUSETTS; MEDICALLY UNINSURED; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POVERTY; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; UNITED STATES; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 33745165602     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.379     Document Type: Article

References (32)

1. American Heart Association. Heart Disease and Stroke Statistics - 2005 Update. Dallas, TX: American Heart Association, 2004.
2. Casper MI, Barnett E, Halverson JA, et al. Women and heart disease: An atlas of racial and ethnic disparities in mortality, 2nd ed. Morgantown, WV: Office for Social Environment and Health Research, West Virginia University, 2000.
3. Shumaker SA, Czajkowski SM. A review of health-related quality of life and psychosocial factors in women with cardiovascular disease. Ann Behav Med 1993;15:149.
4. Casper ML, Barnett E, Williams GI Jr, et al. Atlas of stroke mortality: Racial, ethnic, and geographic disparities in the United States. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, 2003:8.
5. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and socioeconomic differences in cardiovascular disease risk factors: Findings for Women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 1998;280:356.
6. Ford ES, Will JC, De Proost Ford MA, Mokdad AH. Health insurance status and cardiovascular disease risk factors among 50-64-year-old U.S. women: Findings from the Third National Health and Nutrition Examination Survey. J Womens Health 1998;7:997.
7. Will JC, Farris PF, Sanders CG, Stockmyer CK, Finkelstein EA. Health promotion interventions for disadvantaged women: Overview of the WISEWOMAN projects. J Womens Health 2004;13:484.
8. Stoddard AM, Palombo R, Troped PJ, Sorenson G, Will JC. Cardiovascular disease risk reduction: The Massachusetts WISEWOMAN Project. J Womens Health 2004;13:539.
9. Staten LK, Gregory-Mercado KY, Ranger-Moore J, et al. Provider counseling, health education, and community health workers: The Arizona WISEWOMAN project. J Womens Health 2004;13:547.
10. Will JC, Massoudi B, Mokdad A, et al. Reducing risk for cardiovascular disease in uninsured women: Combined results from two WISEWOMAN projects. J Am Med Womens Assoc 2001;56:161.
11. Finkelstein EA, Troped PJ, Will JC, Palombo R. Cost-effectiveness of a cardiovascular disease risk reduction program aimed at financially vulnerable women: The Massachusetts WISEWOMAN project. J Womens Health Gend-Based Med 2002;11:519.
12. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:120.
13. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Full report (NIH Publication No. 02-5215). Washington, DC: National Institutes of Health, National Heart, Lung and Blood Institute. Available at www.nhlbi.nih.gov/guidelines/cholesterol/ Accessed June 4, 2004.
14. Finkelstein EA, Wittenborn JS, Farris RP. Evaluation of public health demonstration programs: The effectiveness and cost-effectiveness of WISEWOMAN. J Womens Health 2004;13:625.
15. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356.
16. StataCorp. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP, 2005.
17. Wonderling D, Langham S, Buxton M, Normand C, McDermott C. What can be concluded from the Oxcheck and British family heart studies: Commentary on cost-effectiveness analyses. BMJ 1996;312:1274.
18. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J. Cost-effectiveness analysis in heart-disease. Part II: Preventive therapies. Prog Cardiovasc Dis 1995;37:243.
19. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA 1989;261:75.
20. Hlatky M. Economic endpoints in clinical trials. Epidemiol Rev 2002;24:80.
21. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199.
22. Fields LE, Burt VL, Cutler JA, Hughes J, Rocella EJ, Sorlie P. The burden of adult hypertension in the United States, 1999 to 2000: A rising tide. Hypertension 2004;44:398.
23. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: US Dept. of Health and Human Services, Centers for Disease Control and Prevention, 2000-2003.
24. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76.
25. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among U.S. adults: Findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107:2185.
26. Bobo JK, Shapiro JA, Schulman J, Wolters CL. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev 2004;13:620.
27. Liao Y, McGee DL, Cooper RS. Prediction of coronary heart disease mortality in blacks and whites: Pooled data from two national cohorts. Am J Cardiol 1999;84:31.
28. D'Agostino RB, Grundy S, Sullivan L, Wilson P. Validation of the Framingham coronary heart disease predictions scores: Results of a multiple ethnic group investigation. JAMA 2001;286:180.
29. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481.
30. Marshall T. Coronary heart disease prevention: Insights from modelling incremental cost effectiveness. BMJ 2003;327:1264.
31. Anderson RN, Smith BL. Deaths: Leading causes for 2001. Natl Vital Stat Rep 2003;52:1.
32. Arias E. United States life tables, 2001. Natl Vital Stat Rep 2004;52:1.